Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
Latest News
All News
EMJ GOLD
Spotlight: March 2024
EMJ GOLD
Say hello to EMJ GOLD!
EMJ GOLD
Spotlight: February 2024
EMJ GOLD
Spotlight: January 2024
Latest Articles
All Articles
EMJ GOLD
Roundtable: How can pharma close the gender health gap?
Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.
EMJ GOLD
Get ready for Gen Z doctors
A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?
EMJ GOLD
Has medical affairs reached 'strategic pillar' standing?
The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?
EMJ GOLD
VPAG: the UK's ticket to pharma superpower status?
A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?
Latest Podcasts
All Podcasts
EMJ GOLD
The 2024 pharma forecast
This special episode features three of last year’s guests, who share their predictions for the pharmaceutical industry’s year ahead.
EMJ GOLD
Nurturing the next generation of pharma leaders
Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals.
EMJ GOLD
A patient's right to thrive, not just survive
Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
EMJ GOLD
What motivates and challenges GOLD's guests?
In this episode of GOLD Podcast, Isabel brings you a curated selection of insights from the pharma leaders we have heard from so far. Listen now!
Latest Infographics
All Infographics
EMJ GOLD
Haematology under the microscope
EMJ GOLD
Cardiology under the microscope
EMJ GOLD
Oncology under the microscope
EMJ GOLD
Advancing diversity in clinical trials